FDA - Food and Drug Administration

03/20/2026 | Press release | Distributed by Public on 03/20/2026 13:31

Webcol (Large Alcohol Prep Pads (70% isopropyl alcohol)/Cardinal Health) Recall reason: Microbial Contamination

COMPANY ANNOUNCEMENT

Cardinal Health Issues Voluntary Nationwide Recall of Webcol™ Large Alcohol Prep Pad

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement View Product Photos

Summary

Company Announcement Date: March 19, 2026 FDA Publish Date: March 20, 2026 Product Type: Drugs Reason for Announcement:
Recall Reason Description
Microbial Contamination
Company Name: Cardinal Health Brand Name:
Brand Name(s)
Webcol
Product Description:
Product Description
Large Alcohol Prep Pads (70% isopropyl alcohol)

Company Announcement

FOR IMMEDIATE RELEASE / DUBLIN, Ohio, March 19, 2026 - Cardinal Health has issued a voluntary recall for select lots of Webcol™ Large Alcohol Prep Pads (70% isopropyl alcohol) to the consumer level. The product is being recalled due to microbial contamination identified as Paenibacillus phoenicis.

There is a reasonable probability that use of the contaminated pads may result in local and systemic infections in at-risk populations; patients with impaired immune response, including patients with cancer receiving chemotherapy or poorly controlled diabetes, may develop life-threatening infections such as bacteremia or central nervous system infections.

The Webcol™ Alcohol Prep Pad is used for external use only and utilized for cleansing.

The product was distributed in the U.S., Puerto Rico and Japan between September 2025 and February 2026.

Affected Webcol™ Alcohol Prep Pad lots include the following lot numbers: See Attached Table

Cardinal Health notified its customers by overnight mail on March 2, 2026, with instructions to:

  1. REVIEW inventory for the affected product code.
  2. SEGREGATE and quarantine all affected product upon review of inventory.
  3. DISSEMINATE Cardinal Health's notice to all departments, clinics and external campuses that handle the affected products.
  4. NOTIFY any customers to whom they may have distributed or forwarded affected product about this voluntary recall.
  5. RETURN the acknowledgment form via fax to 614-652-9648 or email directly to [email protected], confirming receipt of this product action.

Consumers with questions regarding this recall can contact Cardinal Health at [email protected] or call 800-292-9332 Monday-Friday between 8am and 5pm EST.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Company Contact Information

Consumers: Cardinal Health 800-292-9332 [email protected]
Media: Casey Sudzina, Media Relations, Cardinal Health (614) 356-3220

Product Photos

FDA - Food and Drug Administration published this content on March 20, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 20, 2026 at 19:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]